The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens.
Yazar
SAVAS, B
Pehlivan, Sacide
OZDOGAN, M
ARTAC, M
BOZCUK, H
AKCAN, S
PEHLIVAN, M
SEVER, T
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Makale [92796]